COGT
Price
$16.39
Change
+$0.03 (+0.18%)
Updated
Oct 17 closing price
Capitalization
2.29B
29 days until earnings call
IMNM
Price
$15.67
Change
-$0.82 (-4.97%)
Updated
Oct 17 closing price
Capitalization
1.36B
29 days until earnings call
Interact to see
Advertisement

COGT vs IMNM

Header iconCOGT vs IMNM Comparison
Open Charts COGT vs IMNMBanner chart's image
Cogent Biosciences
Price$16.39
Change+$0.03 (+0.18%)
Volume$1.16M
Capitalization2.29B
Immunome
Price$15.67
Change-$0.82 (-4.97%)
Volume$1.33M
Capitalization1.36B
COGT vs IMNM Comparison Chart in %
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. IMNM commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and IMNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (COGT: $16.39 vs. IMNM: $15.67)
Brand notoriety: COGT and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 67% vs. IMNM: 95%
Market capitalization -- COGT: $2.29B vs. IMNM: $1.36B
COGT [@Biotechnology] is valued at $2.29B. IMNM’s [@Biotechnology] market capitalization is $1.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, IMNM is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while IMNM’s TA Score has 6 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • IMNM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +0.74% price change this week, while IMNM (@Biotechnology) price change was +12.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

COGT is expected to report earnings on Nov 17, 2025.

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($2.29B) has a higher market cap than IMNM($1.36B). COGT YTD gains are higher at: 110.128 vs. IMNM (47.552). IMNM has higher annual earnings (EBITDA): -187.92M vs. COGT (-299.34M). IMNM has more cash in the bank: 268M vs. COGT (238M). IMNM has less debt than COGT: IMNM (4.14M) vs COGT (60.7M). IMNM has higher revenues than COGT: IMNM (12.6M) vs COGT (0).
COGTIMNMCOGT / IMNM
Capitalization2.29B1.36B168%
EBITDA-299.34M-187.92M159%
Gain YTD110.12847.552232%
P/E RatioN/AN/A-
Revenue012.6M-
Total Cash238M268M89%
Total Debt60.7M4.14M1,465%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
70
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTIMNM
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CISMX13.370.12
+0.91%
Clarkston Partners Institutional
MNMRX15.070.02
+0.13%
Manning & Napier Pro-Blend Mod Term R
SIDRX13.27-0.01
-0.08%
Hartford Schroders Intl Multi-Cp Val SDR
PAIGX23.13-0.02
-0.09%
T. Rowe Price International Value Eq Adv
CETAX14.29-0.02
-0.14%
Centerstone Investors A

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+0.18%
SPHDF - COGT
63%
Loosely correlated
N/A
NUVL - COGT
52%
Loosely correlated
+2.32%
IDYA - COGT
50%
Loosely correlated
+5.67%
CGON - COGT
49%
Loosely correlated
-0.93%
IMNM - COGT
48%
Loosely correlated
-4.97%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-4.97%
IDYA - IMNM
59%
Loosely correlated
+5.67%
NRIX - IMNM
54%
Loosely correlated
-1.89%
RLAY - IMNM
54%
Loosely correlated
-0.31%
ARWR - IMNM
53%
Loosely correlated
-5.54%
SYRE - IMNM
52%
Loosely correlated
+1.03%
More